ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $149,000 | +27.4% | 36,284 | +10.8% | 0.00% | – |
Q4 2021 | $117,000 | +30.0% | 32,749 | +50.2% | 0.00% | – |
Q1 2021 | $90,000 | +73.1% | 21,799 | +66.3% | 0.00% | – |
Q4 2020 | $52,000 | -16.1% | 13,105 | -42.5% | 0.00% | – |
Q2 2020 | $62,000 | -82.9% | 22,801 | -79.3% | 0.00% | -100.0% |
Q2 2019 | $362,000 | +583.0% | 110,029 | +314.1% | 0.00% | – |
Q4 2017 | $53,000 | +178.9% | 26,569 | +136.1% | 0.00% | – |
Q3 2016 | $19,000 | -85.7% | 11,254 | -91.1% | 0.00% | -100.0% |
Q2 2016 | $133,000 | +329.0% | 126,474 | +755.1% | 0.00% | – |
Q2 2015 | $31,000 | -68.4% | 14,791 | -72.4% | 0.00% | -100.0% |
Q3 2014 | $98,000 | – | 53,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |